Product Formulas Sample Clauses

POPULAR SAMPLE Copied 1 times
Product Formulas. The Company agrees to provide SafeScience, simultaneously with execution of this Agreement, with all the formulas and other information necessary for manufacture of the Products (the "Product Formulas"). Upon addition of any new Product to Appendix A, the Company shall promptly provide all the formulas and other information necessary for manufacture thereof to SafeScience.
View SourceView Similar (2)
Product Formulas. 10 4.8 Regulatory Issues............................................................10
View Source
Product Formulas. DC will utilize detailed recipes and/or formulas to manufacture the Products pursuant to this agreement (“Formulas”) which Formulas are delivered herewith and made part hereof. In consideration of Annie’s commitment to purchase the Products from DC and the additional consideration of [***] Dollars ($[***]) over and above the price for the Products, paid by Annie’s to DC in accordance with Section 11, DC conveys the Formulas to Annie’s on the Effective Date of this Agreement.
View SourceView Similar (3)
Product Formulas. Schedule 5.7 is a true and complete copy of the current formulations and production methodologies of each Product. Such formulations and methodologies are sufficient to enable Purchaser to manufacture all of the Products.
View SourceView Similar (3)
Product Formulas. The product formulas are proprietary to OGI but the mixing knowhow and Blending process are the property of UI. UI agrees not to sell or reveal these Processes to any other party other than OGI during the term of this agreement. UI shall not reverse compile, reverse assemble, disassemble or attempt in any manner to change, in whole or in part, any of the formulas. UI shall provide OGI any required modifications that UI makes to any formula during the period that such formula is being manufactured by UI.
View Source
Product Formulas. As of the Closing Date, Roche shall have provided Connetics with the current formulations and production methodologies of the Product, which are sufficient to enable Connetics to manufacture the Product as it is currently manufactured by or on behalf of Roche including, without limitation, all existing information in written or electronic form that relates to chemical processes for the production of API and intermediates in the preparation of the Product, the in-process analytical controls for the production of the API and the Product, the process, formulation and development reports generated for the preparation of the Product, the analytical methods and validation for the quality control release of the API and the Product, and the stability protocols, stability indicating methods and stability dates for the API and the Product.
View Source
Product Formulas. Connetics shall have, prior to the date of the Closing, supplied Prometheus with a true and complete copy of the current formulations and production methodologies of the Product and that the same is sufficient to enable Prometheus to manufacture the Product as it is manufactured by or on behalf of Connetics immediately prior to the Closing Date, including, without limitation, all existing information in written or electronic form that relates to chemical processes for the production of API and intermediates in the preparation of the Product, the in-process analytical controls for the production of the API and the Product, the process, formulation and development reports generated for the preparation of the Product, the analytical methods and validation for the quality control release of the API and the Product, and the stability protocols, stability indicating methods and stability dates for the API and the Product.
View Source
Product Formulas. Effective April 1, 2001 Original Licensee hereby assigns to Licensee all right, title, and interest in and to the formulas, trademarks, copyrights, and products label artwork (“Assigned Materials”), currently used to manufacture the Products, reserving only its right, title, and interest in the ▇▇▇▇ “Famous Fixin’s.” Original Licensee shall deliver all Assigned Materials to Licensee within thirty (30) days of the execution of the Agreement.
View Source

Related to Product Formulas

  • SHOP DRAWINGS, PRODUCT DATA AND SAMPLES 4.12.1 Shop Drawings are drawings, diagrams, schedules and other, data specially prepared for the Work by the Contractor or any Subcontractor, manufacturer, supplier or distributor to illustrate some portion of the Work. 4.12.2 Product Data are illustrations, standard schedules, performance charts, instructions, brochures, diagrams and other information furnished by the Contractor to illustrate a material, product or system for some portion of the Work. 4.12.3 Samples are physical examples which illustrate materials, equipment or workmanship and establish standards by which the Work will be judged. 4.12.4 The Contractor shall review, approve and submit, with reasonable promptness and in such sequence as to cause no delay in the Work or in the work of the State or any separate contractor, all Shop Drawings, Product Data and Samples required by the Contract Documents. 4.12.5 By approving and submitting Shop Drawings, Product Data and Samples, the Contractor represents that he / she has determined and verified all materials, field measurements, and field construction criteria related thereto, or will do so, and that he / she has checked and coordinated the information contained within such submittals with the requirements of the Work and of the Contract Documents. 4.12.6 The Contractor shall not be relieved of responsibility for any deviation from the requirements of the Contract Documents by the Architect's approval of Shop Drawings, Product Data or Samples under Subparagraph 2.2.7 of these General Conditions unless the Contractor has specifically informed the Architect and the State in writing of such deviation at the time of sub- mission and the Architect and the State has given written approval to the specific deviation. The Contractor shall not be relieved from responsibility for errors or omissions in the Shop Drawings, Product Data or Samples by the Architect's approval thereof. 4.12.7 The Contractor shall direct specific attention, in writing or on resubmitted Shop Drawings, Product Data or Samples, to revisions other than those requested by the Architect on previous submittals. 4.12.8 No portion of the Work requiring submission of a Shop Drawing, Product Data or Sample shall be commenced until the submittal has been approved by the Architect as provided in Subparagraph 2.2.7 of these General Conditions. All such portions of the Work shall be in accordance with approved submittals.

  • Product NYISO will provide Energy Resource Interconnection Service and Capacity Resource Interconnection Service to Developer at the Point of Interconnection.

  • Product Labeling The labeling of all Licensed Products sold or offered for sale under this Agreement shall expressly state that the Licensed Product is manufactured under a license from the Medicines Patent Pool.

  • New Products You agree to comply with NASD Notice to Members 5-26 recommending best practices for reviewing new products.

  • Combination Products If a LICENSED PRODUCT is sold to any third party in combination with other products, devices, components or materials that are capable of being sold separately and are not subject to royalties hereunder (“OTHER PRODUCTS,” with the combination of products being referred to as “COMBINATION PRODUCTS” and the Other Product and Licensed Product in such Combination Product being referred to as the “COMPONENTS”), the NET SALES of such LICENSED PRODUCT included in such COMBINATION PRODUCT shall be calculated by multiplying the NET SALES of the COMBINATION PRODUCT by the fraction A/(A+B), where A is the average NET SALES price of such LICENSED PRODUCT in the relevant country, as sold separately, and B is the total average NET SALES price of all OTHER PRODUCTS in the COMBINATION PRODUCT in the relevant country, as sold separately. If, in any country, any COMPONENT is not sold separately, NET SALES for royalty determination shall be determined by the formula [C / (C+D)], where C is the aggregate average fully absorbed cost of the Licensed Product components during the prior Royalty Period and D is the aggregate average fully absorbed cost of the other essential functional components during the prior Royalty Period, with such costs being determined in accordance with generally accepted accounting principles. To the extent that any SUBLICENSE INCOME relates to a COMBINATION PRODUCT or is otherwise calculated based on the value of one or more licenses or intellectual property rights held by the COMPANY, an AFFILIATE or SUBLICENSEE, COMPANY shall determine in good faith and report to THE PARTIES the share of such payments reasonably attributable to COMPANY’s or such AFFILIATE’s sublicense of the rights granted hereunder, based upon their relative importance and proprietary protection, which portion shall be the SUBLICENSE INCOME. THE PARTIES shall have the right to dispute such sharing determination in accordance with the dispute provisions of the AGREEMENT.